Primed stem cells and uses thereof to treat inflammatory conditions in joints
AssigneeHowmedica Osteonics Corp.
InventorsLin Song, Marc Long
Life of this patent
Estimating the term…
Abstract
Disclosed are methods of treating inflammation within a synovial joint, comprising administering to the joint a composition comprising primed stem or progenitor cells in an amount effective to enhance recovery, and a pharmaceutically acceptable carrier.
Claims20
A method of treating inflammation in a synovial joint, comprising administering to the synovial joint a composition comprising stem or progenitor cells in an amount effective to enhance recovery, and a pharmaceutically acceptable carrier, wherein prior to the administration, the stem or progenitor cells are exposed to an inflammatory in vitro environment.
Dependencies are inferred from the claim text.